Newton Biocapital's approach is to support promising startup projects as well as neglected or undervalued late-stage life sciences companies in the "core of Europe" and Japan. We invest in therapeutic, diagnostic, medical device, clinical nutrition and digital biotech companies that share our…
Employees: 11-50
Investment Type: Venture Capital
Investment Stage: Series B; Series C; Series D; Series E; Series F; Series G; Series H
Portfolio 13
| Date | Name | Website | Total Raised | Location |
| 08.06.2023 | Santero Me... | santero.be | $8.57M | - |
| 15.10.2018 | Sequana Me... | sequanamedical.com | $88.84M | Belgium, E... |
| - | Perseus Pr... | ppmx.com | - | - |
| - | Dim3 | dim3.com | - | Belgium, L... |
| - | ABOLERIS P... | aboleris-pharma.com | - | France, Pa... |
| - | EPICS THER... | epicstherapeutics.com | - | Belgium, H... |
| - | DeuterOnco... | deuteroncology.com | $6.12M | - |
| - | J-Pharma | j-pharma.com | - | Japan, Oku... |
| - | ChromaCure | chromacure.com | - | - |
| - | NEUVASQ BI... | neuvasq.com | - | Belgium, H... |
Show more
Mentions in press and media 2
| Date | Title | Description |
| 16.12.2025 | Bioxodes: €5.5 Million Series A Extension Raised To Advance BIOX-101 Toward Pivotal Hemorrhagic Stroke Trial | Bioxodes SA, a clinical-stage biopharmaceutical company developing therapies for thrombotic and inflammatory diseases, has raised a €5.5 million Series A extension to continue preparations for a potentially registrational Phase 2b trial of ... |
| 15.10.2018 | Sequana Medical establishes new corporate headquarters in Ghent, Belgium and raises € 8.5 million from leading Belgian investors including Newton Biocapital, PMV and SFPI-FPIM as well as existing shar... | Ghent, Belgium: 15 October 2018 – Sequana Medical NV, a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant ascites and other flu... |